Aili Aierken, Balun Li, Peng Liu, Xuedi Cheng, Zheng Kou, Ning Tan, Mengfei Zhang, Shuai Yu, Qiaoyan Shen, Xiaomin Du, Bold Bayar Enkhbaatar, Juqing Zhang, Rui Zhang, Xiaolong Wu, Ruibin Wang, Xin He, Na Li, Sha Peng, Wenwen Jia, Congrong Wang, Jinlian Hua
BACKGROUND: Mesenchymal stem cells (MSCs) are promising candidates for tissue regeneration and disease treatment. However, long-term in vitro passaging leads to stemness loss of MSCs, resulting in failure of MSC therapy. This study investigated whether the combination of melatonin and human umbilical cord mesenchymal stem cells (hUC-MSCs) was superior to hUC-MSCs alone in ameliorating high-fat diet and streptozocin (STZ)-induced type II diabetes mellitus (T2DM) in a mouse model. METHODS: Mice were divided into four groups: normal control (NC) group; T2DM group; hUC-MSCs treatment alone (UCMSC) group and pretreatment of hUC-MSCs with melatonin (UCMSC/Mel) group...
April 12, 2022: Stem Cell Research & Therapy